GABA release in posterior hypothalamus across sleep-wake cycle Inactivation of neuronal activity in this area is known to induce sleep. Most PH neurons decrease unit discharge during slow-wave sleep (SWS) relative to wake and rapid eye movement sleep. In the present study, we sought to examine potential sources of inhibition or disfacilitation underlying the reduction of PH unit activity during SWS in the cat. We employed the microdialysis technique in conjunction with high-performance liquid chromatography methods for the quantification of glutamate, glycine, and y-aminobutyric acid (GABA) release. We found a selective increase in GABA release during SWS in the PH. Glutamate and glycine levels were unchanged across the sleep-wake cycle. Microinjection of the GABAA-receptor agonist muscimol, into the same areas from which microdialysis samples were collected, increased SWS time. Our studies support the hypothesis that GABA release in the posterior hypothalamus mediates inhibition of posterior hypothalamic neurons, thereby facilitating sws.
glutamate; glycine; microdialysis; cats; muscimol IT WAS SUGGESTED as early as 1918 that the posterior hypothalamus (PH) plays an important role in maintenance of the waking state. Von Economo (32) found that patients with lesions of the PH were hypersomnolent. Subsequently, it was shown that electrolytic or cytotoxic lesions of this area in rats and cats produced large increases in slow-wave sleep (SWS) (12, 14, 15) . Reversible inactivation of cells in this area by the microinjection of the y-aminobutyric acid (GABA) type A receptor agonist muscimol increases sleep time in intact cats and restores sleep in cats made insomniac by the administration of parachlorophenylalanine (PCPA) or preoptic area (POA) lesion (l&21).
Anatomic and electrophysiological studies also support the hypothesis that the PH makes a significant contribution to the maintenance of electroencephalographic (EEG) arousal. The rat PH is the origin of direct projections to the cerebral cortex (22). Most neurons in this area of the cat exhibit their highest rates of firing during active wake and phasic rapid eye movement (REM) sleep (20, 27) . Firing rates of most neurons in the PH are lowest during SWS. This pattern of activity resembles that of mesencephalic reticular neurons (MRF) (24, 27) .
Recently, we demonstrated changes in GABA release opposite to the predominant state-related pattern of activity in the dorsal raphe (DR) and locus ceruleus (LC) nuclei of the cat (16, 17) . GABA release in each of these areas was greatest during REM sleep, a time when noradrenergic and serotonergic units cease discharge (6, 13, 18) . In this study, we sought to determine whether GABA, glutamate, and/or glycine concentrations in the PH fluctuate as a function of sleep-wake state. In vivo microdialysis in combination with highperformance liquid chromatography (HPLC) techniques was used to measure the release of these amino acid neurotransmitters in the PH as a function of sleep-wake state. To further characterize the action of GABA at our microdialysis sites in the PH, we performed microinjections of the GABA*-receptor agonist muscimol and determined its effect on sleep-wake state organization.
METHODS

AND EXPERIMENTAL PROCEDURES
Aseptic surgery was performed on six cats using pentobarbital sodium anesthesia (35 mg/kg ip). Screw electrodes were placed in the posterior orbit and sensorimotor cortex for the recording of eye movements and EEG. Tripolar electrodes were implanted into the lateral geniculate nucleus for the recording of ponto-geniculo-occipital spikes. Flexible stainless steel wires were inserted into the neck musculature for the recording of electromyographic activity. Stainless steel guide cannulas (21-gauge thin wall) were stereotaxically implanted at sites 1 mm above the PH. Coordinates for the two sites were anterior 10, lateral 2.5, and ventral 2.5 (25).
Cats were maintained on a 12:12-h light-dark cycle with lights on between 7:00 A.M. and 7:00 P.M. At least 2 wk after surgery, animals were connected to a recording cable for polygraphic recording. A 50-mm concentric microdialysis probe with a 2-mm semipermeable membrane 0.27 mm in diameter was inserted to a position 3 mm beyond the tip of the guide. The molecular cutoff size of the dialysis membrane was 50 kDa; our probes have recovery rates between 12 and 17% in vitro. The probe was perfused at a rate of 2 ul/min with artificial cerebrospinal fluid (aCSF) of the following composition (in mM): 145 Nat, 2.7 K+, 1.0 Mg2+, 1.2 Ca2+, 152.1 Cl-, and 2.0 Na2HP04, pH 7.4. The delay between probe insertion and sample collection was 17 h. Microdialysis samples were then collected from immediately adjacent 4-to lo-min periods of SWS, REM sleep, quiet wake, and active wake. SWS and REM sleep were identified by standard criteria (28). During quiet wake, cats were lying down with raised head or in the sphinx posture. Active wake was elicited by engaging cats in play behavior using a string and consisted of continuous motor activity.
Sample collection was timed precisely by the use of an Eicom fraction collector incorporating a lo-min delay to account for the time for perfusate to travel from the tip of the probe to the outlet of the tubing. Samples were immediately frozen on dry ice and stored at -40°C for subsequent analysis.
The content of the amino acids glutamate, glycine, and GABA in microdialysis samples was analyzed by HPLC with
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on August 12, 2008 ajpregu.physiology.org Downloaded from electrochemical detection using a system manufactured by Eicom. The system employed a 4.6 x 150-mm C1s separation column (Rainin) and a glassy-carbon electrode held at +700 mV. Equal volumes ofthe collected samples were reacted with 5 pl of 4 mM o-pthaldialdehyde and 2-mercaptoethanol for 2 min before injection onto the separation column. The mobile phase flow rate was set at either 1.0 or 1.2 ml/min. The mobile phase consisted of 0.1 M sodium phosphate buffer with 35% methanol at a pH between 6.06 and 6.14. The pH of the mobile phase was adjusted to obtain the best separation of the compounds of interest. Separation of the GABA peak was especially dependent on precise maintenance of the pH. The assay was able to detect 10 fmol of the amino acids glutamate, glycine, and GABA, with a signal-to-noise ratio of 3:l. Repeated assays of identical amino acid standard solutions were performed and indicated a peak height variability of ~2%. The assay consistently showed a linear response of amino acid peak height to step increases of amino acid concentration One additional microinjection was made in a PH site not used for microdialysis collection. Microinjections were made at 9:00 A.M.; polygraphic recordings were made for 6 h after the administration of muscimol. The microinjection took place over the course of 1 min; the injection cannula was retained in place for an additional minute before removal. The injection cannula was positioned 1 mm beyond the tip of the guide cannula. Sham and vehicle (0.5 ul aCSF) microinjections made at each site were used as controls for analysis of the effects of muscimol administration.
The order of sham, vehicle, and muscimol injections was randomized. Sham injections consisted of insertion of a dry injection cannula and mock injection over the same time course as vehicle and muscimol injections.
Animals were perfused under deep pentobarbital sodium anesthesia (50 mg/kg ip), and the brains were removed for histological verification of microdialysis collection sites. Fiftymicrometer brain stem slices from the PH were stained with neutral red to localize dialysis and microinjection sites.
RESULTS
Microdialysis samples were collected from a total of eight sites in five animals. Probe placements are summarized in Fig. 1 . All microdialysis and muscimol microinjection sites were found to lie within posterior hypothalamic areas where muscimol microinjections have been shown to induce SWS (11). These areas also contain neurons exhibiting reduced activity during SWS compared with waking (20, 26) .
It was possible to compare the release of GABA, glutamate, and glycine in active versus quiet wake in nine pairs of samples collected during adjacent time periods from five of the eight collection sites. There was no consistent difference in the release of each of these amino acid neurotransmitters in both waking states as determined by paired t-tests. Therefore, data from quiet wake and active wake samples for these sites were combined for comparison with SWS and REM sleep values.
The content of GABA was analyzed in samples from 17 individual sleep-wake cycles; the number of cycles collected at each of the eight sites varied between one and five. The content of GABA in samples collected during SWS was 8.67 t 0.80 fmoYu1 (Fig. 2) . GABA release during SWS was greater than that during wake and REM sleep in 13 of the 17 cases (P < 0.05, sign test). Samples from the four sleep-wake cycles in which GABA release did not increase were collected from four different microdialysis sites. Figure 3 depicts GABA peaks in chromatograms corresponding to samples collected during wake, SWS, and REM sleep in an individual sleep-wake cycle. Figure 4 depicts GABA content in microdialysis samples from an individual site collected over the course of two consecutive sleepwake cycles.
No significant differences in glycine or glutamate release as a function of state were found. Glutamate release during SWS, REM sleep, and wake was 0.55 5 0.05, 0.64 t 0.08, and 0.50 t 0.04 pmol/ul. Glycine release during SWS, REM sleep, and wake was 0.76 t 0.09,0.73 t 0.04, and 0.72 t 0.11 pmol/pl.
A total of six microinjections of muscimol into the PH were made. In each case, sham and vehicle microinjections were also made for comparison. In five cases, the site of injection was the same as that previously used for microdialysis collection. Muscimol produced increases in SWS in each case (17% increase over combined sham and vehicle controls, P < 0.01, analysis of variance with Newman-Keuls post hoc t-tests). SWS increases were accompanied by decreases in wake and REM sleep (Fig. 5) . It should be noted that the percentage of time spent in SWS in the control conditions was ~50% over a 6-h period. Thus SWS time was increased over control amounts under conditions where the percentage of time spent in sleep was already quite high. there is a population of GABAergic neurons projecting to this region that are maximally active during SWS. The increase in SWS time after muscimol microinjections corroborates the findings of others in suggesting that inhibition of posterior hypothalamic neurons is an important step in the production of synchroni zed cortical EEG and SWS and is sufficient to trigger sleep onset (11) The lack of any change in glutamate release across the sleep-wake cycle suggests that disfacilitation of an excitatory glutamatergic PH input is unlikely to be a major factor underlying the decrease in PH unit activity linked to SWS. Glutamate and glycine release was also unchanged as a function of sleep-wake state in the LC and DR nuclei (16, 17) . Glutamate and glycine levels in all states were -100 times higher than GABA levels recovered from the same probes. In the absence of electrical, pharmacological, or mechanical stimulation, the content of glutamate and/or glycine release in microdialysis samples may better reflect the extracellular concentration of glutamate and glycine derived from metabolic processes. These findings may indicate that the microdialysis technique is not well suited to the resolution of relatively small increments in hypothalamic glutamate and/or glycine release that may occur in conjunction with changes in sleep-wake state.
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The increased GABA release in the PH during SWS could result from the increased firing of GABA neurons found within the PH itself. Although a population of GABAergic neurons in the PH has been identified (9) The present finding builds on our previous findings in the DR and LC nuclei demonstrating that GABA release across the sleep-wake cycle is opposite that of the predominant state-related profile of unit discharge (16, 17) . To ge th er, these findings suggest that the production of both SWS and REM sleep is, in part, an acti ve process mediated by GABAergic neu rons. During sleep, we propose tha .t GABA counteracts excitatory inputs in the DR and LC nuclei and PH through the opening of KS and Cl-channels by activation of GABAB and GABAA receptors, respectively. Finally, the findings of this study and previous studies in the LC and DR nuclei suggest that at least two distinct populations of GABAergic neurons a re maximally active, respectively, in SWS and REM sleep.
There are several explanations for the decrease of REM sleep time after the microinjection of muscimol.
4.
First, the activation of posterior hypothalamic neurons may be essential for the production of REM sleep. Such activation could be an essential component for EEG 5. desynchronization during REM sleep, given the inactivity of serotonergic and noradrenergic neurons (6, 13, 16) that normally contribute to EEG desynchronization during wake (4, 31). Alternatively, GABAergic inhibition of hypothesiz ed posterior hypothala mic thermoregulatory and/or cardiovascul ar control mechanisms could preclude the production of REM sleep (26).
7.
Several investigators have suggested that the production of cortical EEG desynchronization is a function of the combined activity of several neuronal groups, each of which innervate large numbers of thalamic or cortical neurons. This concept is consistent with studies demonstrating that axon-sparing lesions of the PH, the MRF, and the pedunculopontine (PPN) nucleus have only transient effects on the production of EEGdesynchronized states (3, 33) . The present findings also support this concept. GABAergic inhibition of posterior hypothalamic activity did not completely block the spontaneous generation of EEG desynchronization during REM sleep and waking.
Rather, activation of the GABA* receptor in this region by muscimol microinjection merely increased SWS time. Thus it is likely that SWS time was increased by the inhibition of one of the several systems contributing to cortical activ ,ation. In this respect, it will be of special i nterest i n the future to determine whether the decreased activity of neurons in the MRF and PPN during SWS is also accompanied by an increased release of GABA.
In conclusion, the present findings suggest that increased GABA release mediates inhibition of wakingand REM sleep-active neurons during SWS. In contrast, we previously found that GABArelease in the LC and DR increases during REM sleep (16, 17) . Together, these findings indicate that state-related profiles of GABA release are region-specific and add to evidence that GABA neurons are essential for the production of specific sleep-wake states.
